ArticleArchives of pharmacal research2025

The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma.

Jihye You et al.PubMed ↗Publisher ↗

No numbers read from the abstract.